Aramark (ARMK)
Aramark (ARMK)
| Cash Flow | 2026-04-03 | 2026-01-02 | 2025-10-03 | 2025-06-27 |
|---|---|---|---|---|
| Net income from continuing operations | NaN | NaN | 326,870 | NaN |
| Net income | 164,113 | -37,424 | NaN | 71,952 |
| Depreciation and amortization | 132,160 | 125,954 | 124,260 | 121,822 |
| Asset write-downs | 0 | 6,058 | 8,946 | NaN |
| Reduction of contingent consideration liability | NaN | NaN | -11,127 | NaN |
| Loss (gain) on equity investments, net (see note 1) | NaN | NaN | -19,465 | NaN |
| Increase in contingent consideration liability (see note 11) | 0 | 0 | NaN | 0 |
| Deferred income taxes | 14,561 | 22,869 | 14,482 | -3,194 |
| Share-based compensation expense | 18,477 | 16,316 | 13,922 | 14,425 |
| Receivables | -7,482 | 250,180 | -133,351 | 56,092 |
| Inventories | 39,008 | -8,145 | 25,449 | -17,219 |
| Prepayments and other current assets | 5,907 | 16,509 | 12,937 | -14,555 |
| Accounts payable | -24,876 | -255,257 | 391,186 | -23,898 |
| Accrued expenses | 183,952 | -446,911 | 424,582 | -86,781 |
| Payments made to clients on contracts | 49,960 | 101,408 | 23,660 | 12,603 |
| Changes in other noncurrent liabilities | NaN | NaN | -15,577 | NaN |
| Changes in other assets | NaN | NaN | -63,807 | NaN |
| Other operating activities | 61,231 | 12,222 | -28,058 | 19,272 |
| Net cash provided by operating activities of continuing operations | NaN | NaN | 921,035 | NaN |
| Net cash used in operating activities | 656,200 | -1,114,825 | NaN | 76,677 |
| Purchases of property and equipment and other | 101,276 | 122,156 | 142,201 | 111,378 |
| Disposals of property and equipment | 6,431 | 2,123 | 18,342 | 1,150 |
| Purchases of marketable securities | NaN | NaN | 0 | 0 |
| Proceeds from marketable securities | NaN | NaN | 43,936 | 0 |
| Acquisition of certain businesses, net of cash acquired | 58,185 | 32,753 | 524 | 15,243 |
| Acquisition of certain equity investments | 13,769 | NaN | 25,877 | NaN |
| Proceeds from sale of equity investments | NaN | NaN | 0 | NaN |
| Other investing activities | -4,004 | 934 | 1,922 | 6,237 |
| Net cash (used in) provided by investing activities of continuing operations | NaN | NaN | -722,424 | NaN |
| Net cash used in investing activities | -414,426 | 229,619 | NaN | -131,708 |
| Proceeds from long-term borrowings | -229,929 | 233,294 | -253,768 | 118,833 |
| Payments of long-term borrowings | 61,337 | 25,471 | 70,945 | 438,813 |
| Net change in revolving credit facility | 140,366 | NaN | NaN | NaN |
| Net change in funding under the receivables facility | 0 | 625,000 | -570,000 | -16,000 |
| Payments of dividends | 31,531 | 31,537 | 27,599 | 27,539 |
| Distribution from vestis | NaN | NaN | 0 | NaN |
| Proceeds from issuance of common stock | 16,092 | 3,196 | 6,546 | 20,048 |
| Repurchase of common stock | 25,060 | 41,262 | 29,671 | 30,873 |
| Payments for contingent considerations | 6,625 | 27,072 | 33,604 | NaN |
| Other financing activities | -5,225 | -452 | 65,036 | -12,843 |
| Net cash (used in) provided by financing activities of continuing operations | NaN | NaN | -234,628 | NaN |
| Net cash provided by operating activities | NaN | NaN | 0 | NaN |
| Net cash used in investing activities | NaN | NaN | 0 | NaN |
| Net cash provided by financing activities | NaN | NaN | 0 | NaN |
| Net cash provided by discontinued operations | NaN | NaN | 0 | NaN |
| Net cash provided by financing activities | 220,617 | 699,017 | NaN | -387,187 |
| Effect of foreign exchange rates on cash and cash equivalents and restricted cash | -1,757 | 1,422 | -3,871 | 25,916 |
| (decrease) increase in cash and cash equivalents and restricted cash | 32,451 | -198,802 | 149,440 | -416,302 |
| Cash and cash equivalents and restricted cash, beginning of period | 508,342 | 707,144 | 557,704 | 974,006 |
| Cash and cash equivalents and restricted cash, end of period | 540,793 | 508,342 | 707,144 | 557,704 |